RISE RCT for Nurse Leaders (RISE)

June 27, 2023 updated by: AdventHealth

A Randomized Controlled Trial of RISE for Nurse Leaders

The purpose of this study is to determine whether RISE for Nurse Leaders has a significant impact on nurse leaders' post-traumatic growth, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Florida
      • Orlando, Florida, United States, 32804
        • AdventHealth Orlando

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult ≥ 18 years old
  • Licensed as an RN
  • Unit-based nurse leader (i.e., assistant nurse manager, nurse manager) employed by AdventHealth in a hospital-based setting at the Altamonte Springs, Apopka, Celebration, Daytona Beach, DeLand, East Orlando, Fish Memorial, Kissimmee, New Smyrna Beach, Orlando, Palm Coast, Waterman, or Winter Park campus
  • Able to speak, read, and understand English fluently
  • Able to provide informed consent
  • Willing and able to comply with all study procedures and requirements for the duration of the study.

Exclusion Criteria:

  • Employed as a direct care nurse or in another level of nursing leadership (i.e., director of nursing, executive leader)
  • A study participant of IRBNet #1504917 titled A Pilot Study of RISE for Nurse Managers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Intervention group will attend the RISE for Nurse Leaders program, which consists of nine 90-minute weekly psychoeducational group sessions facilitated by a licensed mental health counselor (LMHC)
Behavioral: RISE for Nurse Leaders Program
Psychoeducational sessions designed to impact resilience, insight, self-compassion, and empowerment
Active Comparator: Wait-list control group
Control group will attend the RISE for Nurse Leaders program after the 3-month wait-list period
Behavioral: RISE for Nurse Leaders Program
Psychoeducational sessions designed to impact resilience, insight, self-compassion, and empowerment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Posttraumatic Growth Inventory
Time Frame: Group comparison from baseline to 3-month follow-up
21 item questionnaire with a scale of 0-5, with 0 meaning I did not experience this change as a result of my crisis; and 5 meaning I experienced this change to a very great degree as a result of my crisis
Group comparison from baseline to 3-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Index of Affective Job Satisfaction
Time Frame: Group comparison from baseline to 3-month follow-up
4 item questionnaire with a scale of 1-5, with 1 meaning strongly disagree; and 5 meaning strongly agree
Group comparison from baseline to 3-month follow-up
Brief Resilience Scale
Time Frame: Group comparison from baseline to 3-month follow-up
6 item questionnaire with a scale of 1-5, with 1 meaning strongly disagree; and 5 meaning strongly agree
Group comparison from baseline to 3-month follow-up
General Self-Efficacy Scale
Time Frame: Group comparison from baseline to 3-month follow-up
10 item questionnaire with a scale of 1-4, with 1 meaning not at all true; and 4 meaning exactly true
Group comparison from baseline to 3-month follow-up
Perceived Stress Scale
Time Frame: Group comparison from baseline to 3-month follow-up
10 item questionnaire with a scale of 0-4, with 0 meaning never; and 4 meaning very often
Group comparison from baseline to 3-month follow-up
Professional Quality of Life (ProQOL) Scale
Time Frame: Group comparison from baseline to 3-month follow-up
30 item questionnaire with a scale of 1-5 with 1 meaning never; and 5 meaning very often
Group comparison from baseline to 3-month follow-up
Psychological Empowerment Instrument
Time Frame: Group comparison from baseline to 3-month follow-up
12 item questionnaire with a scale of A-G, with A meaning very strongly disagree; and G meaning very strongly agree
Group comparison from baseline to 3-month follow-up
Self-Reflection and Insight Scale
Time Frame: Group comparison from baseline to 3-month follow-up
20 item questionnaire with a scale of 1-6; with 1 meaning strongly disagree; and 6 meaning strongly agree
Group comparison from baseline to 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AdventHealth

Investigators

  • Principal Investigator: Amanda T Sawyer, PhD, AdventHealth

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2022

Primary Completion (Actual)

March 15, 2023

Study Completion (Actual)

May 15, 2023

Study Registration Dates

First Submitted

February 15, 2022

First Submitted That Met QC Criteria

February 15, 2022

First Posted (Actual)

February 24, 2022

Study Record Updates

Last Update Posted (Actual)

June 28, 2023

Last Update Submitted That Met QC Criteria

June 27, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1839775

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on RISE for Nurse Leaders Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe